Duration of drug levels in mice as indicated by residual antileukemic efficacy.
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D003520:Cyclophosphamide / Q000008:administration & dosage*; D005260:Female; D007279:Injections, Subcutaneous; D007939:Leukemia L1210 / Q000188:drug therapy*; D008297:Male; D051379:Mice; D009603:Nitroso Compounds / Q000008:administration & dosage*
D000970:Antineoplastic Agents; D009603:Nitroso Compounds; D003520:Cyclophosphamide